- Webinar
- December 2021
- 90 Minutes
Global
From €135EUR$150USD£115GBP
- Webinar
- December 2021
- 90 Minutes
Global
From €175EUR$195USD£150GBP
- Webinar
- December 2021
- 60 Minutes
Global
From €171EUR$190USD£146GBP
- Book
- April 2018
- 486 Pages
- Book
- January 2012
- 123 Pages
- Webinar
- 60 Minutes
Global
From €135EUR$150USD£115GBP
- Training
- 2 Hours
Global
- Report
- November 2024
- 90 Pages
Australia
From €1169EUR$1,301USD£1,001GBP
€1670EUR$1,859USD£1,430GBP
- Book
- February 2025
- 432 Pages
- Book
- March 2024
- 528 Pages
- Book
- September 2023
- 384 Pages
- Book
- December 2022
- 384 Pages
- Book
- June 2022
- 336 Pages
- Book
- August 2021
- 432 Pages
- Book
- October 2020
- 384 Pages
- Book
- October 2020
- 432 Pages
- Book
- May 2020
- 300 Pages
- Book
- November 2019
- 368 Pages

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more